100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Posacad GR Tablet
Cadila Healthcare Ltd.
₹7,500
Our Recommendation
Candipoz GR 100mg Tablet 10s
650+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Severe fungal infections
Customers also bought
More About Posacad
Benefits
In Severe fungal infections : Posacad GR Tablet is an antifungal medicine. It works by killing and stopping the growth of fungus that is causing the infection. It helps treat severe infections in severely immunocompromised patients, cancer patients, and those undergoing blood transfusion.The dose and duration of treatment will depend on what you are being treated for. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side Effects
Side effects of Posacad Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Posacad Headache Rash Decreased appetite Decreased white blood cell count (neutrophils)Dizziness Electrolyte imbalance Fatigue Fever Decreased potassium level in blood Increased liver enzymes Insomnia (difficulty in sleeping)Itching Sleepiness Taste change Weakness
How to use
How to use Posacad Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Posacad GR Tablet is to be taken with food.
How it works
How Posacad Tablet works Posacad GR Tablet is an antifungal medication. It kills and stops the growth of the fungi by destroying its cell membrane, thereby treating your skin infection.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Posacad GR Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Posacad GR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Posacad GR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Posacad GR Tablet may cause side effects which could affect your ability to drive.As you may feel dizzy, sleepy, or have blurred vision while taking Posacad GR Tablet, which may affect your ability to drive.
Posacad GR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Posacad GR Tablet may be needed. Doctor consultation is advised.Regular monitoring of kidney function tests is advised while taking this medicine. Use of Posacad GR Tablet is not recommended in patients with moderate to severe kidney disease.
Posacad GR Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Posacad GR Tablet may not be needed in these patients. Please consult your doctor.
What if I forget to take it?
If a dose of Posacad GR Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Zydus Tower Satellite Cross Road Ahmadabad - 380015
References
Bennett JE. Antifungal Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1581-82
Sheppard D, Lampiris HW. Antifungal Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 841
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1135-36
Medscape. Posaconazole (29 Mar. 2019)
Posaconazole. Kenilworth, New Jersey: Schering Plough; 2006 (29 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (29 Mar. 2019)
Noxafil (25 Jul. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
